|国家预印本平台
首页|中医药治疗冠心病PCI术后焦虑抑郁的研究进展

中医药治疗冠心病PCI术后焦虑抑郁的研究进展

中文摘要英文摘要

冠心病是威胁人类健康的主要疾病之一。我国接受经皮冠状动脉介入(PCI)治疗的患者数量逐年攀升,但术后焦虑抑郁高发,严重影响患者的康复进程及生活质量。中医药在改善PCI术后焦虑抑郁中具有整体调节、疗效显著、副作用少的特点。本文系统综述中医药干预PCI术后焦虑抑郁的病因病机与治疗进展。

Coronary heart disease (CHD) is one of the major diseases threatening human health. The number of patients undergoing percutaneous coronary intervention (PCI) in China has been increasing annually, but postoperative anxiety and depression are highly prevalent, severely affecting patients’ rehabilitation progress and quality of life. Traditional Chinese medicine (TCM) has been recognized for its advantages in improving anxiety and depression after PCI, including holistic regulation, significant efficacy, and fewer side effects. In this paper, a systematic review was conducted to summarize the etiology, pathogenesis, and therapeutic advancements of TCM interventions for anxiety and depression in patients after PCI.

丁喜凤、刘赵朋、钟颖琦、郑景辉

广西中医药大学研究生院广西中医药大学广西中医药大学广西中医药大学附属瑞康医院

10.12201/bmr.202503.00078

中医学内科学临床医学

冠心病经皮冠状动脉介入术后焦虑抑郁中医药

coronary heart diseasepost-percutaneous coronary interventionanxietydepressiontraditional Chinese medicine

丁喜凤,刘赵朋,钟颖琦,郑景辉.中医药治疗冠心病PCI术后焦虑抑郁的研究进展[EB/OL].(2025-03-17)[2025-08-16].https://www.biomedrxiv.org.cn/article/doi/bmr.202503.00078.点此复制

评论